» Articles » PMID: 22554955

Gender, Sex Steroid Hormones, and Alzheimer's Disease

Overview
Journal Horm Behav
Date 2012 May 5
PMID 22554955
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Age-related loss of sex steroid hormones is a established risk factor for the development of Alzheimer's disease (AD) in women and men. While the relationships between the sex steroid hormones and AD are not fully understood, findings from both human and experimental paradigms indicate that depletion of estrogens in women and androgens in men increases vulnerability of the aging brain to AD pathogenesis. We review evidence of a wide range of beneficial neural actions of sex steroid hormones that may contribute to their hypothesized protective roles against AD. Both estrogens and androgens exert general neuroprotective actions relevant to a several neurodegenerative conditions, some in a sex-specific manner, including protection from neuron death and promotion of select aspects of neural plasticity. In addition, estrogens and androgens regulate key processes implicated in AD pathogenesis, in particular the accumulation of β-amyloid protein. We discuss evidence of hormone-specific mechanisms related to the regulation of the production and clearance of β-amyloid as critical protective pathways. Continued elucidation of these pathways promises to yield effective hormone-based strategies to delay development of AD.

Citing Articles

Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit.

Rosende-Roca M, Garcia-Gutierrez F, Cantero-Fortiz Y, Alegret M, Pytel V, Canabate P Alzheimers Res Ther. 2025; 17(1):27.

PMID: 39844303 PMC: 11753069. DOI: 10.1186/s13195-024-01656-9.


Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease.

Biel D, Suarez-Calvet M, Dewenter A, Steward A, Roemer S, Dehsarvi A EMBO Mol Med. 2025; 17(2):235-248.

PMID: 39794447 PMC: 11822105. DOI: 10.1038/s44321-024-00190-3.


Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.

Ng T, Udeh-Momoh C, Lim M, Gleerup H, Leifert W, Ajalo C Alzheimers Dement. 2024; 21(2):e14420.

PMID: 39737743 PMC: 11848381. DOI: 10.1002/alz.14420.


Risk of glaucoma to subsequent dementia or cognitive impairment: a systematic review and meta-analysis.

Wang X, Chen W, Zhao W, Miao M Aging Clin Exp Res. 2024; 36(1):172.

PMID: 39162899 PMC: 11335947. DOI: 10.1007/s40520-024-02811-w.


Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency.

Chueh K, Juan T, Lu J, Wu B, Lin R, Mao J Int J Mol Sci. 2024; 25(9).

PMID: 38732143 PMC: 11084446. DOI: 10.3390/ijms25094927.


References
1.
King D, Arendash G, Crawford F, Sterk T, Menendez J, Mullan M . Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res. 1999; 103(2):145-62. DOI: 10.1016/s0166-4328(99)00037-6. View

2.
Rocca W, Amaducci L, Schoenberg B . Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol. 1986; 19(5):415-24. DOI: 10.1002/ana.410190502. View

3.
Kaufman J, Vermeulen A . The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005; 26(6):833-76. DOI: 10.1210/er.2004-0013. View

4.
Yu W . Sex difference in neuronal loss induced by axotomy in the rat brain stem motor nuclei. Exp Neurol. 1988; 102(2):230-5. DOI: 10.1016/0014-4886(88)90098-2. View

5.
Jaffe A, Toran-Allerand C, Greengard P, Gandy S . Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem. 1994; 269(18):13065-8. View